A new type of peroxisomal disorder with variable expression in liver and fibroblasts

Hanna Mandel, Marck Espeel, Frank Roels, Neomi Sofer, Anthony Luder, Theodore C. Iancu, Anna Aizin, Moshe Berant, Ronald J.A. Wanders, Ruud B.H. Schutgens

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

We describe two siblings, presently 5 and 9 years of age, who had neurodegenerative symptoms after the first year of life. Although they lacked clinical characteristics of a peroxisomal disorder, they had elevated levels of plasma very long chain fatty acids, pipecolic and phytanic acids, and abnormal bile acid intermediates, which suggested a generalized peroxisome deficiency disorder. Immunocytochemical study and electron microscopy of the liver disclosed absence of peroxisomes in approximately 90% of hepatocytes. However, the remaining 10% of the hepatocytes had numerous normal-looking peroxisomes containing catalase activity and catalase antigen. Alanine glyoxylate aminotransferase and the peroxisomal β-oxidation enzymes acyl-coenzyme A oxidase and 3-ketoacyl coenzyme A thiolase were also present in the organelles. Both cell types were grouped in clusters. In contrast to most of the liver cells, fibroblasts cultured from skin biopsy specimens had normal peroxisomal functions. Thus this defect in peroxisome biogenesis is characterized by variable expression in different tissues (liver vs fibroblasts), as well as within individual cells in the same tissue (liver mosaicism). Awareness of the heterogeneity in tissue expression of peroxisomal disorders could be of critical importance in prenatal diagnosis. (J PEDIATR 1994;125:549-55).

Original languageEnglish
Pages (from-to)549-555
Number of pages7
JournalJournal of Pediatrics
Volume125
Issue number4
DOIs
StatePublished - Oct 1994

Bibliographical note

Funding Information:
Supported by the Joseph Elias Fund for Medical Research, B. Rappaport-Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, and by the Belgium National Fond voor Wetenschappelijk Onderzoek (to Drs. Espeel and Roels), and the Belgian National Lottery grant No. 9.0027.88.

Funding

Supported by the Joseph Elias Fund for Medical Research, B. Rappaport-Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, and by the Belgium National Fond voor Wetenschappelijk Onderzoek (to Drs. Espeel and Roels), and the Belgian National Lottery grant No. 9.0027.88.

FundersFunder number
Belgian National Lottery9.0027.88
Belgium National Fond voor Wetenschappelijk Onderzoek
Joseph Elias Fund for Medical Research
Technion-Israel Institute of Technology, Haifa, Israel

    Fingerprint

    Dive into the research topics of 'A new type of peroxisomal disorder with variable expression in liver and fibroblasts'. Together they form a unique fingerprint.

    Cite this